{"transactions":[{"id":2903980,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-19T18:21:31.000Z","date":"2021-01-19","kind":"tax_withholding","acquired":false,"shares":1685,"price":6.68,"value":11255.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted\nstock units."}],"balance_after":116062,"source":{"system":"sec-edgar","filing":"0001209191-21-004095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919121004095/doc4.xml","form_type":"4"}},{"id":2914764,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T16:37:19.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":33000,"derivative":{"exercise_price":5.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-21-002114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919121002114/doc4.xml","form_type":"4"}},{"id":2914763,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-06T16:37:19.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":2739,"price":5.8,"value":15886.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to performance restricted stock unit award."}],"balance_after":117747,"source":{"system":"sec-edgar","filing":"0001209191-21-002114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919121002114/doc4.xml","form_type":"4"}},{"id":2914762,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-06T16:37:19.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 33.33% of which vested\non January 4, 2021 upon the achievement of a non-financial performance goal."}],"balance_after":120486,"source":{"system":"sec-edgar","filing":"0001209191-21-002114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919121002114/doc4.xml","form_type":"4"}},{"id":2914761,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-06T16:37:19.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":14667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,279 shares acquired on November 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":113819,"source":{"system":"sec-edgar","filing":"0001209191-21-002114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919121002114/doc4.xml","form_type":"4"}},{"id":3029771,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock","published_at":"2020-09-16T17:21:41.000Z","date":"2020-09-15","kind":"tax_withholding","acquired":false,"shares":1557,"price":6.25,"value":9731.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon\nthe vesting of certain shares of common stock subject to a performance restricted stock unit award."}],"balance_after":97873,"source":{"system":"sec-edgar","filing":"0001209191-20-050734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919120050734/doc4.xml","form_type":"4"}},{"id":3029770,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock","published_at":"2020-09-16T17:21:41.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 15, 2020 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,090 shares acquired on May 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":99430,"source":{"system":"sec-edgar","filing":"0001209191-20-050734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919120050734/doc4.xml","form_type":"4"}},{"id":3182483,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-03T17:47:31.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":4.68,"exercise_date":"2021-03-31","expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-023378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919120023378/doc4.xml","form_type":"4"}},{"id":3306173,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2020-01-21T17:35:38.000Z","date":"2020-01-19","kind":"tax_withholding","acquired":false,"shares":2044,"price":7.18,"value":14675.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted\nstock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,893 shares acquired on May 20, 2019 and November 20, 2019 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":92840,"source":{"system":"sec-edgar","filing":"0001209191-20-004311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919120004311/doc4.xml","form_type":"4"}},{"id":3321691,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T20:03:15.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":7.77,"exercise_date":"2021-01-03","expiration_date":"2030-01-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-001428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919120001428/doc4.xml","form_type":"4"}},{"id":3384394,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-31T18:27:38.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":6.47,"exercise_date":"2020-10-31","expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-054654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919119054654/doc4.xml","form_type":"4"}},{"id":3448765,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T17:59:39.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":7500,"derivative":{"exercise_price":7.69,"exercise_date":"2020-07-31","expiration_date":"2029-07-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-044336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919119044336/doc4.xml","form_type":"4"}},{"id":3690502,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2019-01-22T19:13:56.000Z","date":"2019-01-19","kind":"tax_withholding","acquired":false,"shares":2044,"price":8.78,"value":17946.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":91991,"source":{"system":"sec-edgar","filing":"0001209191-19-004861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919119004861/doc4.xml","form_type":"4"}},{"id":3707578,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T20:35:47.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":29000,"derivative":{"exercise_price":7.58,"exercise_date":"2020-01-03","expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001209191-19-001575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919119001575/doc4.xml","form_type":"4"}},{"id":3912052,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2018-05-31T19:03:26.000Z","date":"2018-05-31","kind":"sale","acquired":false,"shares":21551,"price":9.25,"value":199346.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All 21,551 of the shares were acquired on May 18, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":94035,"source":{"system":"sec-edgar","filing":"0001209191-18-034494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919118034494/doc4.xml","form_type":"4"}},{"id":3942249,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2018-05-08T20:37:39.000Z","date":"2018-05-04","kind":"tax_withholding","acquired":false,"shares":7616,"price":4.22,"value":32139.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock."}],"balance_after":94035,"source":{"system":"sec-edgar","filing":"0001209191-18-028718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919118028718/doc4.xml","form_type":"4"}},{"id":4092173,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-23T17:42:10.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":52500,"derivative":{"exercise_price":4.65,"exercise_date":"2019-01-19","expiration_date":"2028-01-19","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001209191-18-004973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919118004973/doc4.xml","form_type":"4"}},{"id":4092172,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2018-01-23T17:42:10.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,004 shares acquired on May 19, 2017 pursuant to the Issuer's 2014 Employee Stock Purchase Plan and 3,043 shares acquired on November 20, 2017 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":101651,"source":{"system":"sec-edgar","filing":"0001209191-18-004973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919118004973/doc4.xml","form_type":"4"}},{"id":4331436,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2017-05-05T18:25:51.000Z","date":"2017-05-04","kind":"tax_withholding","acquired":false,"shares":8192,"price":1.34,"value":10977.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 147 shares acquired on May 20, 2015 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, 2,643 shares acquired on November 20, 2015 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, 5,694 shares acquired on May 20, 2016 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, and 2,908 shares acquired on November 18, 2016 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":80604,"source":{"system":"sec-edgar","filing":"0001209191-17-030443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919117030443/doc4.xml","form_type":"4"}},{"id":4497731,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:20:51.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":17605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person's employment agreement with the Issuer entitles him to an annual cash bonus. The Reporting Person voluntarily elected to be paid 20% of his 2016 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer."}],"balance_after":17605,"derivative":{"exercise_price":1.23,"exercise_date":"2017-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":17605},"source":{"system":"sec-edgar","filing":"0001209191-17-002391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919117002391/doc4.xml","form_type":"4"}},{"id":4497730,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":143690,"kind":"person","name":"MORNEAU MICHAEL","position":1,"cik":"0001517780","reported_name":"MORNEAU MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:20:51.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":95000,"derivative":{"exercise_price":1.23,"exercise_date":"2018-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-17-002391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517780/000120919117002391/doc4.xml","form_type":"4"}}]}